Screening of Lactobacillus plantarum LPH10 and Its Anti-inflammatory Properties: Acid and Bile Salt Tolerance, Bacteriostatic Activity and Regulation of NF-κB/IRF Pathways
- PMID: 40833721
- DOI: 10.1007/s12602-025-10725-w
Screening of Lactobacillus plantarum LPH10 and Its Anti-inflammatory Properties: Acid and Bile Salt Tolerance, Bacteriostatic Activity and Regulation of NF-κB/IRF Pathways
Abstract
Inflammatory diseases pose a significant threat to human health, and probiotics have increasingly drawn substantial attention for their anti-inflammatory potential. In this research, a model of inflammation was constructed using J774-Dual reporter cells. Lactobacillus plantarum LPH10 with anti-inflammatory properties was screened from Yangzhou pickles. Its characteristics of acid tolerance, bile salt tolerance, bacteriostatic ability, and inhibition of the Salmonella-induced inflammation were evaluated. The results demonstrated that LPH10 exhibited excellent tolerance in simulated gastric acid (pH 3.0) and small intestinal bile salt (0.3%) environments, maintaining high survival rates at both 2 h and 4 h, indicating remarkable acid and bile salt resistance. Bacteriostatic assays demonstrated that LPH10 was effective in restraining the growth of Salmonella enteritidis and Escherichia coli. Moreover, LPH10 displayed sensitivity to a broad spectrum of antibiotics and did not notably affect the viability of RAW264.7 macrophages, which indicated its safety. LPH10 was discovered to be able to potently suppress the activation of the NF-κB and IRF signaling pathways triggered by LPS and S. enteritidis. In the LPS-induced inflammation model, LPH10 downregulated the expression of proinflammatory cytokines such as IL-1β, IL-6, and TNF-α, while upregulating the expression of the anti-inflammatory cytokine IL-10. In the Salmonella-induced inflammation model, LPH10 also regulated the expression levels of inflammatory cytokines, thereby exerting potent anti-inflammatory effects. Overall, L. plantarum LPH10 was successfully screened due to its multiple beneficial properties. This study provides a solid theoretical basis and experimental support for the screening and application of functional anti-inflammatory probiotics and will provide new approaches and probiotic candidates for the development of anti-inflammatory foods and the treatment of inflammatory diseases.
Keywords: Lactobacillus plantarum LPH10; Acid and bile salt tolerance; Anti-inflammation; Bacteriostatic activity; NF-κB/IRF pathways.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Clinical Trial Number: Not applicable.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Mahonia bealei (Fort.) Carr. Leaf extract modulates the TLR2/MyD88/NF-κB signaling pathway to inhibit PGN-induced inflammation in RAW264.7 cells.J Ethnopharmacol. 2025 Mar 26;344:119510. doi: 10.1016/j.jep.2025.119510. Epub 2025 Feb 17. J Ethnopharmacol. 2025. PMID: 39971016
-
Lactobacillus plantarum with lignin prevents Helicobacter pylori mediated DSS-colitis through improved intestinal integrity and reducing colonic inflammation in C57BL/6J mice.J Sci Food Agric. 2025 Sep;105(12):6330-6340. doi: 10.1002/jsfa.14374. Epub 2025 May 21. J Sci Food Agric. 2025. PMID: 40396390
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Kim KT, Kim JW, Kim SI, Kim S, Nguyen TH, Kang CH (2021) Antioxidant and anti-inflammatory effect and probiotic properties of lactic acid bacteria isolated from canine and feline feces. Microorganisms 9(9):1971. https://doi.org/10.3300/microorganisms09091971 - DOI - PubMed - PMC
-
- Lee ES, Song EJ, Nam YD, Lee SY (2018) Probiotics in human health and disease: from nutribiotics to pharmabiotics. J Microbiol 56(11):773–782. https://doi.org/10.1007/s12275-018-8293-y - DOI - PubMed
-
- Lopez-Santamarina A, Gonzalez EG, Lamas A, Mondragon ADC, Regal P, Miranda JM (2021) Probiotics as a possible strategy for the prevention and treatment of allergies. A narrative review. Foods 10(4):701. https://doi.org/10.3390/foods10040701 - DOI - PubMed - PMC
-
- Yu P, Ke C, Guo J, Zhang X, Li B (2020) Lactobacillus plantarum L15 alleviates colitis by inhibiting LPS-mediated NF-κB activation and ameliorates DSS-induced gut microbiota dysbiosis. Front Immunol 11:575173. https://doi.org/10.3389/fimmu.2020.575173 - DOI - PubMed - PMC
-
- Kariyawasam KMGMM, Lee NK, Paik HD (2022) Effect of set-type yoghurt supplemented with the novel probiotic Lantiplantibacillus plantarum 200655 on physicochemical properties and the modulation of oxidative stress-induced damage. Food Sci Biotechnol 32(3):353–360. https://doi.org/10.1007/s10068-022-01201-0 - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Full Text Sources